BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Division of Gastroenterology//NONSGML Events//EN
CALSCALE:GREGORIAN
X-ORIGINAL-URL:https://gastro.wustl.edu/events/
X-WR-CALDESC:Division of Gastroenterology - Events
BEGIN:VEVENT
UID:20250115T1609Z-1736957350.5708-EO-11028-1@10.73.10.131
STATUS:CONFIRMED
DTSTAMP:20260508T030953Z
CREATED:20250115T155741Z
LAST-MODIFIED:20250115T155748Z
DTSTART;TZID=America/Chicago:20250121T070000
DTEND;TZID=America/Chicago:20250121T080000
SUMMARY: Journal Club
DESCRIPTION: “Efficacy and safety of 48 weeks of guselkumab for patients wi
 th Crohn’s disease: maintenance results from the phase 2\, randomised\, dou
 ble-blind GALAXI-1 trial” Matthew Vincent\, MBBS & “Tofacitinib in Acute Se
 vere Ulcerative Colitis (TACOS): A Randomized Controlled Trial” Qianli Wang
 \, MD\, PhD   Please Contact Beth Buschard-Steiger (bbuscha@wustl.edu) for 
 Zoom Details  
X-ALT-DESC;FMTTYPE=text/html: <h4 style="text-align: center\;">"Efficacy an
 d safety of 48 weeks of guselkumab for patients with Crohn's disease: maint
 enance results from the phase 2\, randomised\, double-blind GALAXI-1 trial"
 </h4><h5 style="text-align: center\;">Matthew Vincent\, MBBS</h5><h4 style=
 "text-align: center\;">&</h4><h4 style="text-align: center\;">"Tofacitinib 
 in Acute Severe Ulcerative Colitis (TACOS): A Randomized Controlled Trial"<
 /h4><h5 style="text-align: center\;">Qianli Wang\, MD\, PhD</h5><p> </p><p 
 style="text-align: center\;">Please Contact Beth Buschard-Steiger (<a href=
 "mailto:bbuscha@wustl.edu">bbuscha@wustl.edu</a>) for Zoom Details</p><p> <
 /p>
CATEGORIES:Journal Club
LOCATION:Zoom
GEO:38.635144;-90.262929
ORGANIZER;CN="Leslie":MAILTO:larnold@wustl.edu
URL;VALUE=URI:https://gastro.wustl.edu/events/event/journal-club-39/
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
DTSTART:20241103T070000
TZNAME:CST
END:STANDARD
END:VTIMEZONE
END:VCALENDAR